Join ATMA CEO David Harder for an update of Oregon’s legalization rollout. If you are a therapy provider wanting to explore how […]
Join ATMA CEO David Harder for an update of Oregon’s legalization rollout. If you are a therapy provider wanting to explore how […]
Join ATMA Co-founders David Harder and Vu Tran for an information session detailing the road map to get psilocybin and MDMA through […]
Join ATMA us for an information session detailing the roles of different types of practitioners in psychedelic-assisted therapy. What role do you […]
The SAP is a Health Canada program that allows individuals to receive psilocybin and MDMA assisted therapy when they have exhausted their search for relief for end-of-life distress, Major Depressive Disorders (MDD) and Post-Traumatic Stress Disorder (PTSD) without success.
Ketamine is an underutilized and lesser known psychedelic for practitioners looking to participate in the much anticipated revolution and legalization of psychedelic-assisted […]
Thursday October 26, 2023 @ 6:00 pm – 7:00 pm MST MAPS recently published the results of their Phase 3B MDMA […]
Thursday November 16, 2023 @ 6:00 pm – 7:00 pm MST Ketamine possesses the potential to disrupt detrimental behavioral patterns, particularly those intertwined […]
ATMA Presents a Live Q&A with Dr. Ben Sessa: Exploring PTSD and Trauma Treatment through Ketamine and MDMA-Assisted Therapy We are proud […]
Thursday December 7, 2023 @ 6:00 pm – 7:00 pm MDT Join our network and begin offering psychedelic-assisted therapy to much needed […]
Join our newsletter for the latest updates, insights, and exclusive offers on everything psychedelic therapy.
